Chapter 12: Enzyme, Kinetics,Inhibition and Control
Q19CP
List some advantages of phosphorylation/ dephosphorylation cascade systems over simple allosteric regulation.
Q19P
Determine the type of inhibition of an enzymatic reaction from the following data collected in the presence and absence of the inhibitor.
[S] (mM) | v鈧 (mM min鈦宦) | v鈧 with I present (mM min鈦宦) |
1 | 1.3 | 0.8 |
2 | 2.0 | 1.2 |
4 | 2.8 | 1.7 |
8 | 3.6 | 2.2 |
12 | 4.0 | 2.4 |
Q1MTE
MORE TO EXPLORE What kind of inhibitor is warfarin (shown in Fig. 12-20) and what enzyme does it inhibit? What is the physiological goal of warfarin therapy? Why do individuals vary in their response to a standard dose of warfarin? Why can a patient鈥檚 genotypic information help a physician choose an effective dose?
Q2.
If you know a reaction鈥檚 half-life, can you determine its rate constant? What other information do you need?
Q2.
The hypothetical elementary reaction has a rate constant of . What is the reaction velocity when the concentration of is ?
Q20.
Estimate KI for a competitive inhibitor when [I] = 5mM gives an apparent value of KM that is three times the KM for the uninhibited reaction.
Q20.
Compare structure-based drug design and combinatorial chemistry as tools for developing drug candidates.
Q21CP
List the factors that influence a drug鈥檚 bioavailability.
Q21P
Is it necessary for measurements of reaction velocity to be expressed in units of concentration per time (M s鈦宦, for example) to calculate an enzyme's KM?
Q22 c.
Summarize the purpose of phases I through III of a clinical trial.